In contrast, inhibiting LIMK1 expression, or blocking LIMK1 activity, reduced the aggressive behavior of human MDA-MB-231 and MDA-MB-435 breast cancer cell lines [13,17]. This evidence concerns the gene LIMK1 and breast carcinoma.